ENTITY
Jinxin Fertility

Jinxin Fertility (1951 HK)

126
Analysis
Health Care • China
Jinxin Fertility Group is a leading international provider of assisted reproductive services (ARS) and assisted reproductive technology (ART). Its core offerings include In Vitro Fertilization (IVF), Intrauterine Insemination (IUI), egg retrieval, embryo transfer, and genetic screening, alongside a range of women's health services. The company is headquartered in Chengdu, China, and was founded in 1951.
more
bullish•Alibaba
•15 Jun 2019 12:14

ECM Weekly (15 Jun 2019) - Budweiser Brewing Co, Jinxin Fertility, Wanda Sports, Hansoh Pharma

Aequitas Research puts out a weekly update on the deals that have been covered by Smartkarma Insight Providers recently, along with updates for...

Share
•14 Jun 2019 15:15

Jinxin Fertility Group IPO: Valuation Reasonable for the Trade-Offs

Jinxin Fertility Co Ltd (1951 HK) is a leading assisted reproductive service (ARS) provider in China and the US. It announced its IPO price...

Logo
1.2k Views
Share
•12 Jun 2019 00:42

Jinxin Fertility Group IPO: 4Q Update Is Good but Is It Sustainable?

Jinxin Fertility Co Ltd (1951 HK) is a leading assisted reproductive service (ARS) provider in China and the US. Its network of ARS medical...

Logo
990 Views
Share
•11 Jun 2019 17:58

Jinxin Fertility (锦欣生殖) IPO - Worth a Look Given the Sector, Existing Shareholders and Cornerstone

Jinxin Fertility Co Ltd (1659778D CH) plans to raise up to US$390m in its Hong Kong IPO. Ke Yan, CFA, FRM has covered most details of the company...

Logo
1.1k Views
Share
•09 Jun 2019 17:57

Jinxin Fertility Group IPO Preview: Baby Boom or Bust?

Jinxin Fertility Co Ltd (1659778D CH) is a leading assisted reproductive service (ARS) provider in China and the US. Its network of ARS medical...

Logo
1.1k Views
Share
x